The Platelet Lipidome Is Altered in Patients with COVID-19 and Correlates with Platelet Reactivity

Alex R Schuurman1, Valentine Léopold1,2, Liza Pereverzeva1

  • 1Center for Experimental and Molecular Medicine (CEMM), Amsterdam University Medical Centers - Location AMC, University of Amsterdam, Amsterdam, The Netherlands.

Insights

This study reveals significant changes in platelet lipids during coronavirus disease 2019 (COVID-19), impacting platelet function. These findings highlight the role of lipidomics in understanding COVID-19 and platelet reactivity.

Area of Science:

  • Biochemistry
  • Hematology
  • Infectious Diseases

Background:

  • Activated platelets contribute to the proinflammatory and prothrombotic state in coronavirus disease 2019 (COVID-19).
  • The lipidomic profile of platelets during infection remains largely unexplored, despite lipids' crucial roles in platelet structure and signaling.

Purpose of the Study:

  • To investigate the platelet lipidome in patients hospitalized with COVID-19.

Main Methods:

  • Untargeted lipidomics was performed on platelets from 25 COVID-19 patients and 23 noninfectious controls.
  • Patients and controls were matched for age, sex, and comorbidities.

Main Results:

  • Significant alterations in 25% of annotated lipids were observed between COVID-19 patients and controls.
  • COVID-19 platelets showed decreased levels of membrane plasmalogens and unsaturated triacylglycerols.
  • Increased abundance of bis(monoacylglycero)phosphate and lysophosphatidylglycerol in COVID-19 platelets correlated with enhanced platelet reactivity.

Conclusions:

  • This study offers the first exploration of the human platelet lipidome during infection, revealing profound changes in COVID-19.
  • Platelet lipid composition is associated with platelet reactivity, suggesting implications for various disease states involving platelet pathophysiology.
Abstract

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.5K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
626